Deviating from the conventional short ad films, its Parakh ads aim to redefine lending with authentic borrower narratives, ...

so we expect there to be more growth coming from these complex injectables that we will add to the portfolio," Piramal said. ...

Piramal Pharma Limited will be hosting a conference call for investors / analysts on 29th January 2025 from 5:30 PM to 6:15 ...

a subsidiary of Piramal Enterprises, focuses on both retail and wholesale lending. The company serves over 1.3 million ...

Piramal Pharma approaches future with cautious optimism amid geopolitical uncertainty and capacity expansion in the US.

Piramal Pharma said that its subsidiary Piramal Critical Care (PCC) has launched Chlorpromazine Hydrochloride for Injection in various strengths in the US market.

Piramal Finance is among the largest national ... Leverage your credit report to access a wide range of financial products and services, from loans to rental agreements. - Peace of Mind: Enjoy ...

The pharmaceutical company's consolidated net profit tumbled 63.6% to Rs 3.68 crore despite of 12.54% increase in revenue from operations to Rs 2,204.22 crore in Q3 FY25 over Q3 FY24.

Stock Market Today: Piramal Enterprises share price gained more than 8% during the the intraday trades on Tuesday. Piramal Enterprises announced that it will be receiving post $140 million deal ...

Power Brands contributed to 48% of total ICH sales - Excluding i-range, which was impacted by regulatory price control, growth in power brands was about 26% for 9MFY25 - Added 16 new products and ...